Preintervention Wait Time and Survival in People With Rheumatic Heart Disease in UgandaANNALS OF THORACIC SURGERYIF3.92024-10-011PRE
Bringing into focus the central domains C3-C6 of myosin binding protein CFRONTIERS IN PHYSIOLOGYIF3.42024-02-290OAAI
Clinical and Socioeconomic Factors Associated With Time to Surgery and Preoperative Mortality in Surgery-Eligible Patients With Rheumatic Valvular Heart Disease in UgandaCIRCULATIONIF38.62023-11-070PRE
Molecular characterization of linker and loop-mediated structural modulation and hinge motion in the C4-C5 domains of cMyBPCJOURNAL OF STRUCTURAL BIOLOGYIF5.12022-06-017OA
Identification of Phosphorylation and Other Post-Translational Modifications in the Central C4C5 Domains of Murine Cardiac Myosin Binding Protein CACS OMEGAIF4.32022-04-183OAAI
cMyBPC phosphorylation modulates the effect of omecamtiv mecarbil on myocardial force generationJOURNAL OF GENERAL PHYSIOLOGYIF2.92021-03-1012OAAI
AAV9 gene transfer of cMyBPC N-terminal domains ameliorates cardiomyopathy in cMyBPC-deficient miceJCI INSIGHTIF6.12020-09-0316OA
Strategies for targeting the cardiac sarcomere: avenues for novel drug discoveryEXPERT OPINION ON DRUG DISCOVERYIF4.92020-02-183OAAI
Lost in translation: Interpreting cardiac muscle mechanics data in clinical practiceARCHIVES OF BIOCHEMISTRY AND BIOPHYSICSIF32019-02-0112OAAI
Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathyINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22018-12-0115OAAI
Impact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility肌球蛋白调节剂Mavacamten对小鼠过度收缩模型的力产生和跨桥行为的影响JOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32018-09-0446OAAI
Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardiumjacc heart failureIF8.42017-10-0142OAAI